One clinical study over three years showed that glucosamine in doses of 1500&nbsp;mg per day is safe to use.<ref>{{cite journal|title=Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial|journal=The Lancet|date=January 2011|volume=357|issue=9252|pages=251–256|url=http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(00)03610-2/fulltext|doi=10.1016/S0140-6736(00)03610-2|last1=Reginster|first1=Jean Yves|last2=Deroisy|first2=Rita|last3=Rovati|first3=Lucio C|last4=Lee|first4=Richard L|last5=Lejeune|first5=Eric|last6=Bruyere|first6=Olivier|last7=Giacovelli|first7=Giampaolo|last8=Henrotin|first8=Yves|last9=Dacre|first9=Jane E|last10=Gossett|first10=Christiane}}</ref>

 


 
Glucosamine with or without chondroitin elevates the [[international normalized ratio]] (INR) in individuals who are taking the [[anticoagulant|blood thinner]], [[warfarin]].<ref name=mlp/><ref name = Pharmacotherapy>{{cite journal|title=Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database|journal=Pharmacotherapy|date=April 2008|pmid=18363538|doi=10.1592/phco.28.4.540|volume=28|issue=4|pages=540–8|author1=Knudsen|first1=J. F.|last2=Sokol|first2=G. H.}}</ref> It may also interfere with the efficacy of [[chemotherapy]] for treating [[cancer]] symptoms.<ref name=mlp/>

 


 
Adverse effects may include stomach upset, constipation, diarrhea, headache, and rash.<ref name="ARC report">{{cite web|title=Complementary and alternative medicines for the treatment of rheumatoid arthritis, osteoarthritis and fibromyalgia|publisher=Arthritis Research UK|pages=34–5|url=http://www.arthritisresearchuk.org/~/media/Files/Arthritis-information/Additional-items/CAM%20Report.ashx?la=en|date=October 2012|accessdate=17 February 2017}}</ref> There are case reports of people who have chronic liver disease and a worsening of their condition with glucosamine supplementation.<ref>{{cite journal|title=Hepatotoxicity associated with glucosamine and chondroitin sulfate in patients with chronic liver disease|journal=World J Gastroenterol.|date=Aug 28, 2013|pages=5381–5384|pmc=3752575|pmid=23983444|doi=10.3748/wjg.v19.i32.5381|volume=19|issue=32|author1=Cerda|first1=C|last2=Bruguera|first2=M|last3=Parés|first3=A}}</ref>  More high-quality clinical research is needed before recommending glucosamine in pregnancy.<ref name=mlp/>

 


 
Since glucosamine is usually derived from the shells of [[shellfish]], it may be unsafe for those with [[shellfish allergy]].<ref>{{cite journal |author=Gray HC, Hutcheson PS, Slavin RG |title=Is glucosamine safe in patients with seafood allergy? |journal=[[The Journal of Allergy and Clinical Immunology]] |volume=114 |issue=2 |pages=459–60 |date=August 2004 |pmid=15341031 |doi= 10.1016/j.jaci.2004.05.050 |last2=Hutcheson |last3=Slavin }}</ref> However, many manufacturers of glucosamine derived from shellfish include a warning that those with a seafood allergy should consult a healthcare professional before taking the product.<ref>{{cite web |url=http://dietarysupplements.nlm.nih.gov/dietary/detail.jsp?name=Kirkland+Signature+Extra+Strength+Glucosamine+with+MSM&contain=11001019&pageD=brand |archiveurl=https://web.archive.org/web/20100304095044/http://dietarysupplements.nlm.nih.gov/dietary/detail.jsp?contain=11001019&name=Kirkland+Signature+Extra+Strength+Glucosamine+with+MSM&pageD=brand |archivedate=4 March 2010 |accessdate=23 April 2015 |title=Kirkland Signature Extra Strength Glucosamine with MSM |date=3 February 2010 |work=Dietary Supplements Labels Database |publisher=U.S. National Library of Medicine}}</ref> Alternative, non-shellfish-derived forms of glucosamine are available.<ref name=VegSources2008>{{cite web|url=http://www.nutraingredients-usa.com/Industry/Another-vegetarian-glucosamine-launched-in-US |title=Another vegetarian glucosamine launched in US |date=January 25, 2008|work=NutraIngredients-USA.com |archiveurl=https://web.archive.org/web/20090417035225/http://www.nutraingredients-usa.com/Industry/Another-vegetarian-glucosamine-launched-in-US |archive-date=April 17, 2009 |deadurl=yes |df= }}</ref>

 


 
Another concern has been that the extra glucosamine could contribute to diabetes by interfering with the normal regulation of the [[hexosamine]] biosynthesis pathway,<ref name="Buse"/> but several investigations found no evidence that this occurs.<ref>{{cite journal |author=Scroggie DA, Albright A, Harris MD |title=The effect of glucosamine-chondroitin supplementation on glycosylated hemoglobin levels in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial |journal=[[Archives of Internal Medicine]] |volume=163 |issue=13 |pages=1587–90 |date=July 2003 |pmid=12860582 |doi=10.1001/archinte.163.13.1587 |last2=Albright |last3=Harris }}</ref><ref>{{cite journal |author=Tannis AJ, Barban J, Conquer JA |title=Effect of glucosamine supplementation on fasting and non-fasting plasma glucose and serum insulin concentrations in healthy individuals |journal=[[Osteoarthritis and Cartilage / OARS, Osteoarthritis Research Society]] |volume=12 |issue=6 |pages=506–11 |date=June 2004 |pmid=15135147 |doi=10.1016/j.joca.2004.03.001 |last2=Barban |last3=Conquer }}</ref> Other studies conducted in lean or obese subjects concluded that oral glucosamine at standard doses does not affect [[insulin resistance]].<ref>{{cite journal |author=Muniyappa R |title=Oral glucosamine for 6 weeks at standard doses does not cause or worsen insulin resistance or endothelial dysfunction in lean or obese subjects |journal=[[Diabetes (journal)|Diabetes]] |volume=55 |issue=11 |pages=3142–50 |date=November 2006 |pmid=17065354 |doi=10.2337/db06-0714 |author2=Karne RJ |author3=Hall G |display-authors=3 |last4=Crandon |first4=S. K. |last5=Bronstein |first5=J. A. |last6=Ver |first6=M. R. |last7=Hortin |first7=G. L. |last8=Quon |first8=M. J. }}</ref><ref>{{cite journal |author=Biggee BA, Blinn CM, Nuite M, Silbert JE, McAlindon TE |title=Effects of oral glucosamine sulphate on serum glucose and insulin during an oral glucose tolerance test of subjects with osteoarthritis |journal=[[Annals of the Rheumatic Diseases]] |volume=66 |issue=2 |pages=260–2 |date=February 2007 |pmid=16818461 |pmc=1798503 |doi=10.1136/ard.2006.058222 |last2=Blinn |last3=Nuite |last4=Silbert |last5=McAlindon }}</ref>

 

